000 01183 a2200361 4500
005 20250511215652.0
264 0 _c19910502
008 199105s 0 0 eng d
022 _a0024-3205
024 7 _a10.1016/0024-3205(91)90438-h
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKonicki, P E
245 0 0 _aThe acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.
_h[electronic resource]
260 _bLife sciences
_c1991
300 _a1411-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aDebrisoquin
_xpharmacology
650 0 4 _aDomperidone
_xpharmacology
650 0 4 _aFemale
650 0 4 _aFluphenazine
_xpharmacology
650 0 4 _aHomovanillic Acid
_xblood
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aReceptors, Dopamine
_xdrug effects
650 0 4 _aSchizophrenia
_xblood
650 0 4 _aTime Factors
700 1 _aOwen, R R
700 1 _aLitman, R E
700 1 _aPickar, D
773 0 _tLife sciences
_gvol. 48
_gno. 14
_gp. 1411-6
856 4 0 _uhttps://doi.org/10.1016/0024-3205(91)90438-h
_zAvailable from publisher's website
999 _c2014338
_d2014338